Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221
Summary of Product Characteristics last updated on the eMC: 01/12/2008
SPC Epanutin Capsules 25, 50, 100 and 300mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/12/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
Date of revision of text on the SPC:   18-Nov-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Section 4.4 - Addition of class warning for anti-epileptics regarding suicidal ideation and behaviour

 

 

Updated on 25/03/2008 and displayed until 01/12/2008
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01/2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

 

6.1 Spelling of excipient updated from BANs to INNs spelling sodium laurilsulfate

10 Date of revision updated

Updated on 28/08/2007 and displayed until 25/03/2008
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.1 - List of Excipients
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   08/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

1. updated to include strength and specify pharmaceutical form

 

2. text reformatted and required statements added.

 

6.1. one excipient updated to include hydrate form and text formatted into list. Sodium lauryl sulphate spelling corrected as per Ph Eur monograph nomenclature.

 

6.3 Packaging description removed

 

6.4 Storage advice amended in line with CPMP guidance.

 

6.5. updated to include required statement

Updated on 02/04/2007 and displayed until 28/08/2007
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.1 - List of Excipients
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   02/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

 
Section 1 Updated to include strength and specify pharmaceutical form
 
Section 2 Text reformatted and required statement added
 
Section 6.1 One excipient updated to include hydrate form and text formatted into list
 
Section 6.5  Updated to include required statement
 
Section 10 Updated date of revision of the text
Updated on 12/03/2007 and displayed until 02/04/2007
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
Date of revision of text on the SPC:   02/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

6.1  List of excipients - the composition of the printing ink has been changed.
Updated on 10/08/2005 and displayed until 12/03/2007
Reasons for adding or updating:
  • Change from BAN to rINN
  • Change to section 4.4 - Special Warnings and Precautions for Use
Updated on 03/06/2005 and displayed until 10/08/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 11/04/2005 and displayed until 03/06/2005
Reasons for adding or updating:
  • Change to section 3 - pharmaceutical form
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 6. 5 - Nature and Contents of Container
Updated on 06/04/2004 and displayed until 11/04/2005
Reasons for adding or updating:
  • Company name change or merger
Updated on 30/09/2003 and displayed until 06/04/2004
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 10 (date of (partial) revision of the text
  • SPC Company name change or merger
Updated on 19/09/2002 and displayed until 30/09/2003
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 9 - Date of Renewal of Authorisation
  • Change to section 10 (date of (partial) revision of the text
Updated on 24/08/2001 and displayed until 19/09/2002
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   phenytoin sodium


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk